Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Barinthus Biotherapeutics (BRNS) Asset Utilization Ratio (2021 - 2026)

Barinthus Biotherapeutics (BRNS) has disclosed Asset Utilization Ratio for 6 consecutive years, with 0.0 as the latest value for Q1 2026.

  • For Q1 2026, Asset Utilization Ratio fell 99.65% year-over-year to 0.0; the TTM value through Mar 2026 reached 0.0, down 99.65%, while the annual FY2024 figure was 0.08, 2313.59% up from the prior year.
  • Asset Utilization Ratio hit 0.0 in Q1 2026 for Barinthus Biotherapeutics, down from 0.0 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.16 in Q4 2022 and bottomed at 0.0 in Q1 2026.
  • Average Asset Utilization Ratio over 5 years is 0.07, with a median of 0.07 recorded in 2022.
  • Year-over-year, Asset Utilization Ratio soared 16323.46% in 2022 and then plummeted 99.65% in 2026.
  • Barinthus Biotherapeutics' Asset Utilization Ratio stood at 0.16 in 2022, then tumbled by 97.8% to 0.0 in 2023, then soared by 2276.96% to 0.09 in 2024, then tumbled by 96.44% to 0.0 in 2025, then tumbled by 88.31% to 0.0 in 2026.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods came in at 0.0, 0.0, and 0.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.